Aclarion, Inc. (ACON) - Dilution Analysis

10-Q filing | 2.5M shares outstanding

8-K filing: Aclarion, Inc. entered into a Securities Purchase Agreement to sell 200,000 shares of common stock at $5.18 per share and pre-funded warrants to purchase up to 1,800,000 shares of common stock in a registered direct offering. ($1.04M proceeds)

10-Q filing | 0.7M shares outstanding

8-K filing: Aclarion, Inc. entered into a Securities Purchase Agreement to sell 64,000 shares of common stock and pre-funded warrants to purchase up to 236,000 shares of common stock in a registered direct offering. ($2.5M proceeds)

10-Q filing | 0.6M shares outstanding

10-Q filing | 0.6M shares outstanding

S-3 filing: The filing is an S-3 shelf registration allowing the company to offer and sell securities for total gross proceeds of up to $150,000,000.

10-K filing | 0.6M shares outstanding

8-K filing: Stock split 1-for-27 | Outstanding: 13,700,000 → 582,000

8-K filing: Aclarion, Inc. reports the completion of several financing transactions in Q1 2025, resulting in a cash balance of approximately $15.2 million and compliance with Nasdaq Listing Rule 5550(b)(1). Series B warrant holders have exercised approximately 87% of their warrants, leading to the issuance of approximately 12.7 million common shares. The company also mentions a 1-335 reverse stock split effective January 30, 2025.

8-K filing: Aclarion, Inc. entered into a Securities Purchase Agreement to sell 506,803 shares of common stock at $9.25 per share in a registered direct offering, with gross proceeds expected to be approximately $4.7 million. ($4.7M proceeds)

8-K filing: Stock split 1-for-335 | Outstanding: 23,100,008 → 500,000

8-K filing: Aclarion, Inc. completed an offering of 100,000 shares of common stock, 143,900,000 pre-funded warrants, 144,000,000 Series A Common Warrants, and 144,000,000 Series B Common Warrants at a price of $0.10 per share (or $0.09999 per Pre-Funded Warrant), resulting in net proceeds of approximately $13.3 million, with Dawson James Securities, Inc. as the underwriter. ($14.4M proceeds)

S-1/A filing: This S-1/A filing registers the offering of common stock, pre-funded warrants, Series A common warrants, and Series B common warrants by Aclarion, Inc., with Dawson James Securities, Inc. as the underwriter.

8-K filing: Aclarion, Inc. entered into a Securities Purchase Agreement to sell 3,380,276 shares of its common stock at a price of $0.142 per share in a registered direct offering, with gross proceeds expected to be approximately $0.5 million. ($0.5M proceeds)

S-1/A filing: This S-1/A filing details a combination offering of common stock and warrants by Aclarion, Inc., with Dawson James Securities, Inc. as the underwriter. The offering includes Series A and B Common Stock Purchase Warrants and Pre-Funded Common Stock Purchase Warrants.

S-1 filing: This S-1 filing outlines a proposed offering of common stock together with Series A and Series B common warrants, and pre-funded warrants to purchase common stock. The company intends to use the net proceeds from this offering to redeem all outstanding shares of its Series B Preferred Stock and Series C Preferred Stock, with the remaining net proceeds to be used to build out the product platforms, expand our sales and marketing efforts, and for general and administration expenses and other general corporate purposes.

8-K filing: Aclarion, Inc. amended its Equity Line Purchase Agreement with White Lion Capital, extending the expiration date to December 31, 2025, adding pricing methods, and issuing 560,915 shares to White Lion as consideration.

10-Q filing | 9.4M shares outstanding

S-3 filing: This S-3 filing covers the resale of up to 27,515,153 shares of common stock by selling stockholders, including shares issuable upon conversion of Series C Convertible Preferred Stock and upon exercise of Common Warrants.

S-1 filing: This S-1 filing relates to the offering and resale by White Lion Capital LLC of up to 20,000,000 shares of Aclarion, Inc.'s common stock.

POS AM filing: This prospectus relates to the offering and resale by White Lion Capital LLC of up to 1,450,000 shares of our common stock, par value $0.00001 per share.

8-K filing: Aclarion, Inc. entered into a securities purchase agreement for a convertible preferred stock and warrants financing, receiving $1,000,000 in gross proceeds from the issuance of 1,000 shares of Series C convertible preferred stock and warrants exercisable for 5,685,049 shares of Common Stock. ($1.0M proceeds)

S-3/A filing: The company intends to offer various securities, including common stock, preferred stock, warrants, subscription rights, and debt securities, for total gross proceeds of up to $50,000,000.

POS AM filing: This prospectus relates to the offering and resale by White Lion Capital LLC of up to 1,450,000 shares of our common stock, par value $0.00001 per share.

S-3 filing: The company may offer and sell common stock, preferred stock, warrants, subscription rights, debt securities or units, for total gross proceeds of up to $50,000,000.

8-K filing: Aclarion, Inc. entered into a subscription agreement to issue 1,000,000 shares of common stock at $0.29 per share for gross proceeds of $290,000 and also entered into a warrant purchase agreement to issue warrants to purchase up to 400,000 shares of common stock. ($0.29M proceeds)

8-K filing: Aclarion, Inc. entered into an exchange agreement to exchange approximately $930,000 of principal and accrued interest on notes for 930 shares of newly issued Series B convertible preferred stock at a purchase price of $1,000 per share. ($0.93M proceeds)

10-Q filing | 8.2M shares outstanding

8-K filing: Aclarion, Inc. entered into a subscription agreement with an institutional investor to issue and sell 400,000 shares of Common Stock at $0.29 per share for gross proceeds of $116,000. ($0.12M proceeds)

10-Q filing | 8.2M shares outstanding

10-K filing | 7.2M shares outstanding

8-K filing: Aclarion, Inc. closed a public offering of 5,175,000 units at $0.58 per unit on February 27, 2024, for gross proceeds of approximately $3.0 million, with each unit comprising one share of common stock or a prefunded warrant and two common warrants. ($3.0M proceeds)

S-1/A filing: This is an S-1/A filing for Aclarion, Inc. regarding a best-efforts offering of up to 3,888,888 Units, with each Unit consisting of one share of common stock and two Common Warrants, and the option to purchase Pre-Funded Warrants in lieu of common stock, with Maxim Group LLC as placement agent.

S-1/A filing: This S-1/A filing details an offering of up to 3,888,888 Units, each consisting of one share of common stock and one Common Warrant, at an assumed price of $1.80 per Unit, along with Pre-Funded Warrants as an alternative to common stock for certain purchasers.

S-1/A filing: Aclarion Inc. files an S-1/A form to offer up to 2,941,176 Units on a best efforts basis, each Unit consisting of one share of common stock and one Common Warrant, with an opportunity to purchase Pre-Funded Warrants under certain beneficial ownership conditions.

S-1/A filing: This S-1/A filing relates to the offering and resale by White Lion Capital LLC of up to 2,500,000 shares of common stock, and the potential sale of common stock to White Lion Capital LLC for up to $7.1 million.

8-K filing: The company issued 500,000 shares of common stock in exchange for approximately $1,185,226 of principal and accrued interest on notes, increasing the outstanding shares to 1,791,375 as of January 26, 2024. ($1.19M proceeds)

8-K filing: Aclarion, Inc. exchanged $157,365.60 of principal and accrued interest on notes for 56,000 shares of common stock at $2.8101 per share on January 22, 2024. ($0.16M proceeds)

S-1 filing: This S-1 filing describes an offering and resale of up to 2,500,000 shares of common stock by White Lion Capital LLC and the potential sale of common stock to White Lion Capital LLC for up to $7.1 million.

8-K filing: Stock split one-for-sixteen | Outstanding: 9,423,382 → 840,000

S-1 filing: This S-1 filing is for Aclarion, Inc.'s offering of up to 25,925,926 Units, each consisting of one share of common stock and one warrant, offered on a best efforts basis through Maxim Group LLC, along with pre-funded warrant options for certain purchasers.

8-K filing: Aclarion, Inc. entered into a securities purchase agreement for an unsecured non-convertible note financing and received $250,000 of gross proceeds, issuing common stock warrants and shares of common stock as a commitment fee.

10-Q filing | 8.5M shares outstanding

S-1/A filing: This S-1/A filing covers the resale of up to 12,000,000 shares of common stock by the selling securityholder, consisting of commitment shares and additional shares that may be sold to White Lion.

8-K filing: Aclarion, Inc. entered into a common stock purchase agreement with White Lion Capital, LLC, issuing 187,500 commitment shares for $75,000 and granting White Lion the option to purchase up to $10,000,000 in aggregate gross purchase price of newly issued shares of the Company's common stock. ($0.08M proceeds)

S-1 filing: This S-1 filing covers the resale of up to 12,000,000 shares of common stock by a selling securityholder and a potential equity line offering up to $10 million.

10-Q filing | 8.3M shares outstanding

S-1/A filing: S-1/A filing details the completion of the first tranche of a PIPE Offering, including the issuance of common stock, common warrants, and pre-funded warrants, along with associated registration rights agreements and risk factors.

S-1 filing: This S-1 filing includes information on a completed PIPE offering where the company issued common stock, warrants to purchase common stock, and promissory notes, with Carter Terry & Co., Inc. acting as placement agent.

10-Q filing | 7.9M shares outstanding

8-K filing: Aclarion, Inc. entered into a securities purchase agreement for a $2.0 million unsecured non-convertible note financing and received $1,250,000 in gross proceeds in the first tranche. In connection with the first tranche closing, the company issued 1,232,156 common stock warrants and will issue 339,360 shares of common stock as a commitment fee.

8-K filing: The company redeemed one share of Series A Preferred Stock for $1,000, and no Series A Preferred Stock remains outstanding.

10-K filing | 7.9M shares outstanding

8-K filing: Aclarion, Inc. entered into a Securities Purchase Agreement with its Executive Chairman, Jeffrey Thramann, to issue and sell one share of Series A Preferred Stock for $1,000. The company also filed a Certificate of Designation for the Series A Preferred Stock, which grants voting rights related to a potential reverse stock split. ($0.0M proceeds)

10-Q filing | 7.8M shares outstanding

10-Q filing | 7.8M shares outstanding

10-Q filing | 0.9M shares outstanding

8-K filing: Aclarion, Inc. completed a public offering of 2,165,000 shares of common stock and 2,489,750 warrants at $4.35 per unit, with Maxim Group LLC as the underwriter, resulting in gross proceeds of approximately $9.4 million and net proceeds of approximately $8.6 million. ($18.8M proceeds)

S-1/A filing: This S-1/A filing describes an offering of 2,000,000 Units, each consisting of one share of common stock and one warrant, with an underwriter over-allotment option for an additional 300,000 shares of common stock and/or 300,000 warrants.

S-1/A filing: This S-1/A filing relates to the proposed offering and sale of Units, each Unit consisting of one share of common stock and one Common Stock Purchase Warrant to purchase one Share, to be issued and sold by the Company.

S-1/A filing: This is an S-1/A filing for an initial public offering of units, each consisting of one share of common stock and one warrant, at an assumed price of $5.50 per unit.

S-1/A filing: This S-1/A filing relates to a unit offering, with each unit consisting of one share of common stock and one warrant. The underwriters also have an over-allotment option.

S-1/A filing: This S-1/A filing is for an offering of 2,727,273 Units, with each Unit consisting of one share of common stock and one Warrant to purchase one share of common stock, at a public offering price of $5.50 per Unit. The underwriters also have an option to purchase an additional 409,091 shares of common stock and/or 409,091 Warrants.

S-1 filing: This is an S-1 filing prospectus summary highlighting certain information regarding an initial public offering including the offering of common stock and warrants.